467 related articles for article (PubMed ID: 23470860)
1. 3',5'Di-O-trityluridine inhibits in vitro flavivirus replication.
De Burghgraeve T; Selisko B; Kaptein S; Chatelain G; Leyssen P; Debing Y; Jacobs M; Van Aerschot A; Canard B; Neyts J
Antiviral Res; 2013 May; 98(2):242-7. PubMed ID: 23470860
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of Dengue and Yellow Fever viruses by heme, cobalt-protoporphyrin IX and tin-protoporphyrin IX.
Assunção-Miranda I; Cruz-Oliveira C; Neris RL; Figueiredo CM; Pereira LP; Rodrigues D; Araujo DF; Da Poian AT; Bozza MT
J Appl Microbiol; 2016 Mar; 120(3):790-804. PubMed ID: 26759117
[TBL] [Abstract][Full Text] [Related]
3. Narasin, a novel antiviral compound that blocks dengue virus protein expression.
Low JS; Wu KX; Chen KC; Ng MM; Chu JJ
Antivir Ther; 2011; 16(8):1203-18. PubMed ID: 22155902
[TBL] [Abstract][Full Text] [Related]
4. A derivate of the antibiotic doxorubicin is a selective inhibitor of dengue and yellow fever virus replication in vitro.
Kaptein SJ; De Burghgraeve T; Froeyen M; Pastorino B; Alen MM; Mondotte JA; Herdewijn P; Jacobs M; de Lamballerie X; Schols D; Gamarnik AV; Sztaricskai F; Neyts J
Antimicrob Agents Chemother; 2010 Dec; 54(12):5269-80. PubMed ID: 20837762
[TBL] [Abstract][Full Text] [Related]
5. Nordihydroguaiaretic acid (NDGA) inhibits replication and viral morphogenesis of dengue virus.
Soto-Acosta R; Bautista-Carbajal P; Syed GH; Siddiqui A; Del Angel RM
Antiviral Res; 2014 Sep; 109():132-40. PubMed ID: 25017471
[TBL] [Abstract][Full Text] [Related]
6. Discovery of Potent Non-nucleoside Inhibitors of Dengue Viral RNA-Dependent RNA Polymerase from Fragment Screening and Structure-Guided Design.
Lim SP; Noble CG; Nilar S; Shi PY; Yokokawa F
Adv Exp Med Biol; 2018; 1062():187-198. PubMed ID: 29845534
[TBL] [Abstract][Full Text] [Related]
7. Guiding dengue vaccine development using knowledge gained from the success of the yellow fever vaccine.
Liang H; Lee M; Jin X
Cell Mol Immunol; 2016 Jan; 13(1):36-46. PubMed ID: 26435066
[TBL] [Abstract][Full Text] [Related]
8. Antiviral activity of lanatoside C against dengue virus infection.
Cheung YY; Chen KC; Chen H; Seng EK; Chu JJ
Antiviral Res; 2014 Nov; 111():93-9. PubMed ID: 25251726
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of dengue virus polymerase by blocking of the RNA tunnel.
Niyomrattanakit P; Chen YL; Dong H; Yin Z; Qing M; Glickman JF; Lin K; Mueller D; Voshol H; Lim JY; Nilar S; Keller TH; Shi PY
J Virol; 2010 Jun; 84(11):5678-86. PubMed ID: 20237086
[TBL] [Abstract][Full Text] [Related]
10. Characterization of an efficient dengue virus replicon for development of assays of discovery of small molecules against dengue virus.
Yang CC; Tsai MH; Hu HS; Pu SY; Wu RH; Wu SH; Lin HM; Song JS; Chao YS; Yueh A
Antiviral Res; 2013 May; 98(2):228-41. PubMed ID: 23499649
[TBL] [Abstract][Full Text] [Related]
11. A pyrazolotriazolopyrimidinamine inhibitor of bovine viral diarrhea virus replication that targets the viral RNA-dependent RNA polymerase.
Paeshuyse J; Letellier C; Froeyen M; Dutartre H; Vrancken R; Canard B; De Clercq E; Gueiffier A; Teulade JC; Herdewijn P; Puerstinger G; Koenen F; Kerkhofs P; Baraldi PG; Neyts J
Antiviral Res; 2009 Jun; 82(3):141-7. PubMed ID: 19428605
[TBL] [Abstract][Full Text] [Related]
12. Ten years of dengue drug discovery: progress and prospects.
Lim SP; Wang QY; Noble CG; Chen YL; Dong H; Zou B; Yokokawa F; Nilar S; Smith P; Beer D; Lescar J; Shi PY
Antiviral Res; 2013 Nov; 100(2):500-19. PubMed ID: 24076358
[TBL] [Abstract][Full Text] [Related]
13. MEK/ERK activation plays a decisive role in yellow fever virus replication: implication as an antiviral therapeutic target.
Albarnaz JD; De Oliveira LC; Torres AA; Palhares RM; Casteluber MC; Rodrigues CM; Cardozo PL; De Souza AM; Pacca CC; Ferreira PC; Kroon EG; Nogueira ML; Bonjardim CA
Antiviral Res; 2014 Nov; 111():82-92. PubMed ID: 25241249
[TBL] [Abstract][Full Text] [Related]
14. Strategies for development of Dengue virus inhibitors.
Noble CG; Chen YL; Dong H; Gu F; Lim SP; Schul W; Wang QY; Shi PY
Antiviral Res; 2010 Mar; 85(3):450-62. PubMed ID: 20060421
[TBL] [Abstract][Full Text] [Related]
15. In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses.
Kampmann T; Yennamalli R; Campbell P; Stoermer MJ; Fairlie DP; Kobe B; Young PR
Antiviral Res; 2009 Dec; 84(3):234-41. PubMed ID: 19781577
[TBL] [Abstract][Full Text] [Related]
16. Dengue Virus Evolution under a Host-Targeted Antiviral.
Plummer E; Buck MD; Sanchez M; Greenbaum JA; Turner J; Grewal R; Klose B; Sampath A; Warfield KL; Peters B; Ramstedt U; Shresta S
J Virol; 2015 May; 89(10):5592-601. PubMed ID: 25762732
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of dengue virus through suppression of host pyrimidine biosynthesis.
Wang QY; Bushell S; Qing M; Xu HY; Bonavia A; Nunes S; Zhou J; Poh MK; Florez de Sessions P; Niyomrattanakit P; Dong H; Hoffmaster K; Goh A; Nilar S; Schul W; Jones S; Kramer L; Compton T; Shi PY
J Virol; 2011 Jul; 85(13):6548-56. PubMed ID: 21507975
[TBL] [Abstract][Full Text] [Related]
18. Establishment and Application of Flavivirus Replicons.
Kümmerer BM
Adv Exp Med Biol; 2018; 1062():165-173. PubMed ID: 29845532
[TBL] [Abstract][Full Text] [Related]
19. RNA interference inhibits yellow fever virus replication in vitro and in vivo.
Pacca CC; Severino AA; Mondini A; Rahal P; D'avila SG; Cordeiro JA; Nogueira MC; Bronzoni RV; Nogueira ML
Virus Genes; 2009 Apr; 38(2):224-31. PubMed ID: 19169857
[TBL] [Abstract][Full Text] [Related]
20. An analogue of the antibiotic teicoplanin prevents flavivirus entry in vitro.
De Burghgraeve T; Kaptein SJ; Ayala-Nunez NV; Mondotte JA; Pastorino B; Printsevskaya SS; de Lamballerie X; Jacobs M; Preobrazhenskaya M; Gamarnik AV; Smit JM; Neyts J
PLoS One; 2012; 7(5):e37244. PubMed ID: 22624001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
